Neurim Pharmaceuticals initiates Phase III study of Paediatric Prolonged-Release Melatonin in children with Autistic Spectrum Disorders, suffering from sleep disturbances

  • Text size: A A A
  • Circadin
  • Recent news

    • Neurim Pharmaceuticals attends the EPA Congress in Warsaw, Poland, April 7-9, 2019
    • Slenyto (PedPRM) is now also available in UK!
    • Slenyto is now available in Finland
  • Partners